Oncolys BioPharma Inc. total revenue, net income and dynamics of changes in Euro today
Oncolys BioPharma Inc. current income in Euro. Net income of Oncolys BioPharma Inc. today amounted to -300 293 000 €. Net income, revenue and dynamics - the main financial indicators of Oncolys BioPharma Inc.. Schedule of the financial report of Oncolys BioPharma Inc. for today. Information on Oncolys BioPharma Inc. net income on the chart on this page is drawn in blue bars. A graph of the value of all Oncolys BioPharma Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
121 851 027.65 €
-77.216 % ↓
-280 468 256.73 €
-446.331 % ↓
31/03/2021
58 470 075.15 €
+29.39 % ↑
-327 423 267.79 €
-
31/12/2020
99 532 593.78 €
-83.944 % ↓
-513 390 291.78 €
-
30/09/2020
66 775 977.07 €
+274.23 % ↑
-822 533 663.87 €
-
31/12/2019
619 914 674.81 €
-
-300 487 226.91 €
-
30/09/2019
17 843 726.11 €
-
-296 203 985.46 €
-
30/06/2019
534 819 574.79 €
-
80 982 777.27 €
-
31/03/2019
45 188 851.11 €
-
-336 406 306.67 €
-
Show:
to
Oncolys BioPharma Inc. financial report charts
The dates of the latest financial statements of Oncolys BioPharma Inc.: 31/03/2019, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Oncolys BioPharma Inc. for today is 30/06/2021. Gross profit Oncolys BioPharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Oncolys BioPharma Inc. is 112 375 000 €
Oncolys BioPharma Inc. quarterly report dates
Cost of revenue Oncolys BioPharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Oncolys BioPharma Inc. is 18 089 000 € Total revenue Oncolys BioPharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Oncolys BioPharma Inc. is 130 464 000 € Operating income Oncolys BioPharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Oncolys BioPharma Inc. is -297 061 000 €
Net income Oncolys BioPharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Oncolys BioPharma Inc. is -300 293 000 € Current assets Oncolys BioPharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Oncolys BioPharma Inc. is 4 994 046 000 € Total assets Oncolys BioPharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Oncolys BioPharma Inc. is 5 197 403 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
104 956 227.25 €
25 381 894.83 €
96 024 557.38 €
29 745 458.74 €
569 674 849.04 €
10 113 157.10 €
526 134 476.17 €
6 395 908.74 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
16 894 800.40 €
33 088 180.31 €
3 508 036.39 €
37 030 518.34 €
50 239 825.76 €
7 730 569.01 €
8 685 098.62 €
38 792 942.37 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
121 851 027.65 €
58 470 075.15 €
99 532 593.78 €
66 775 977.07 €
619 914 674.81 €
17 843 726.11 €
534 819 574.79 €
45 188 851.11 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-277 449 626.90 €
-339 664 035.89 €
-480 724 271.33 €
-473 997 732.96 €
70 538 056.57 €
-291 184 766.19 €
83 461 565.50 €
-340 513 025.52 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-280 468 256.73 €
-327 423 267.79 €
-513 390 291.78 €
-822 533 663.87 €
-300 487 226.91 €
-296 203 985.46 €
80 982 777.27 €
-336 406 306.67 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
399 300 654.55 €
398 134 111.03 €
580 256 865.10 €
540 773 710.04 €
549 376 618.24 €
309 028 492.30 €
451 358 009.28 €
385 701 876.63 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
4 664 349 071.17 €
4 893 159 717.46 €
2 377 615 561.83 €
2 507 631 460.12 €
3 573 815 810.28 €
3 143 273 457.83 €
3 445 193 413.13 €
2 332 097 015.08 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
4 854 280 848.75 €
5 102 514 584.71 €
2 611 799 406.57 €
2 766 860 032.19 €
4 090 893 462.99 €
4 024 812 368.53 €
4 367 593 102.35 €
3 091 947 411 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
4 111 395 301.87 €
4 650 532 675.45 €
1 702 509 088.70 €
1 957 171 422.77 €
2 893 022 320.75 €
2 822 270 382.30 €
2 918 849 724.99 €
2 177 854 557.69 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
489 220 705.58 €
224 878 582.07 €
252 591 695.97 €
239 279 650.53 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
864 874 803.86 €
603 295 399.10 €
651 805 490.20 €
651 478 596.50 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
21.14 %
14.99 %
14.92 %
21.07 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 185 030 442.75 €
4 454 009 786.90 €
1 871 069 490.15 €
2 176 075 321.98 €
3 226 018 659.14 €
3 421 516 969.43 €
3 715 787 612.15 €
2 440 468 814.50 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
-
-
-
Last revenue report of Oncolys BioPharma Inc. was 30/06/2021. According to last financial report total revenue in Oncolys BioPharma Inc. was 121 851 027.65 Euro and changed by -77.216% since last year. Net income in Oncolys BioPharma Inc. was -280 468 256.73 € in last quartal, net income changes to -446.331%.
Current cash Oncolys BioPharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Oncolys BioPharma Inc. is 4 402 007 000 €
Oncolys BioPharma Inc. stocks data
2OB.F stock price
Oncolys BioPharma Inc. stock price today, 2OB.F stock quote.
